The Medicines competitive analysis

Explore patent oppositions filed by The Medicines against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 16, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Further Novel Forms Of Interfering Rna MoleculesATUGENOct 16, 2018
Futher Novel Forms Of Interfering Rna MoleculesSILENCE THERAPEUTICSDec 14, 2017

Explore The Medicines's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 16, 2025
Patent NumberGrant DateTitleTotal Oppositions
Apr 17, 2024Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein Reduction5

Latest publications and patents of The Medicines New

Explore the latest publications and patents granted to The Medicines, showcasing their recent innovations and technological advancements.

Last updated on: Oct 10, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of The Medicines

Apr 17, 2024Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein ReductionGranted And Under Opposition

Latest PTAB cases involving The Medicines

Discover the latest PTAB cases involving The Medicines, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing The Medicines with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 16, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
THE MEDICINES UK2 - - -
ATUGEN - 3 - -
SILENCE THERAPEUTICS28 - 5